T. Glaunsinger

Transfer of Autologous Gene-modified T Cells in HIV-infected Patients with Advanced Immunodeficiency and Drug-resistant Virus.

I. Müller, D. von Laer, S. Naundorf, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

A highly virulent variant of HIV-1 circulating in the Netherlands

Michael J. Rausch, H. Jessen, A. Trkola, 2022, Science.

Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure.

F. Tacke, B. Paulweber, M. Muche, 2022, Journal of hepatology.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Transfer of autologous gene-modified T cells in HIV-infected patients with advanced immunodeficiency and drug-resistant virus.

Felix Hermann, Christopher Baum, J. van Lunzen, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Prevalence of macrolide- and fluoroquinolone-resistant Mycoplasma genitalium strains in clinical specimens from MSM of two STI practices in Berlin, Germany.

T. Ziegler, R. Dumke, T. Glaunsinger, 2019, Journal of global antimicrobial resistance.

MgpB Types among Mycoplasma genitalium Strains from Men Who Have Sex with Men in Berlin, Germany, 2016–2018

R. Dumke, T. Glaunsinger, M. Rust, 2019, Pathogens.

A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine.

Philip R. Johnson, S. Kochhar, J. van Lunzen, 2008, AIDS research and human retroviruses.

Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients

M. Muche, K. Gadow, D. Semela, 2024, JHEP Reports.